Literature DB >> 21142886

The proteome of sickle cell disease: insights from exploratory proteomic profiling.

Susan Yuditskaya1, Anthony F Suffredini, Gregory J Kato.   

Abstract

The expanding realm of exploratory proteomics has added a unique dimension to the study of the complex pathophysiology involved in sickle cell disease. A review of proteomic studies published on sickle cell erythrocytes and plasma shows trends of upregulation of antioxidant proteins, an increase in cytoskeletal defects, an increase in protein repair and turnover components, a decrease in lipid raft proteins and apolipoprotein dysregulation. Many of these findings are consistent with the pathophysiology of sickle cell disease, including high oxidant burden, resulting in damage to cytoskeletal and other proteins, and erythrocyte rigidity. More unexpected findings, such as a decrease in lipid raft components and apolipoprotein dysregulation, offer previously unexplored targets for future investigation and potential therapeutic intervention. Exploratory proteomic profiling is a valuable source of hypothesis generation for the cellular and molecular pathophysiology of sickle cell disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21142886      PMCID: PMC3068560          DOI: 10.1586/epr.10.88

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  103 in total

1.  Molecular defect in the sickle erythrocyte skeleton. Abnormal spectrin binding to sickle inside-our vesicles.

Authors:  O S Platt; J F Falcone; S E Lux
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

2.  Studies of hemoglobin denaturation and Heinz body formation in the unstable hemoglobins.

Authors:  C C Winterbourn; R W Carrell
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

Review 3.  The role of membrane-associated enzymes in regulation of erythrocyte shape and deformability.

Authors:  N Mohandas; S B Shohet
Journal:  Clin Haematol       Date:  1981-02

4.  Spontaneous oxygen radical generation by sickle erythrocytes.

Authors:  R P Hebbel; J W Eaton; M Balasingam; M H Steinberg
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

5.  Plasma and erythrocyte lipids in sickle cell anaemia.

Authors:  J Sasaki; M R Waterman; G R Buchanan; G L Cottam
Journal:  Clin Lab Haematol       Date:  1983

6.  Abnormal vitamin E and glutathione peroxidase levels in sickle cell anemia: evidence for increased susceptibility to lipid peroxidation in vivo.

Authors:  D Chiu; B Lubin
Journal:  J Lab Clin Med       Date:  1979-10

7.  Use of mass spectrometry-based lipidomics to probe PITPalpha (phosphatidylinositol transfer protein alpha) function inside the nuclei of PITPalpha+/+ and PITPalpha-/- cells.

Authors:  A N Hunt; J G Alb; G Koster; A D Postle; V A Bankaitis
Journal:  Biochem Soc Trans       Date:  2004-12       Impact factor: 5.407

8.  Hypocholesterolaemia and anaemia.

Authors:  M P Westerman
Journal:  Br J Haematol       Date:  1975-09       Impact factor: 6.998

9.  A novel phospholipid in irreversibly sickled cells: evidence for in vivo peroxidative membrane damage in sickle cell disease.

Authors:  S K Jain; S B Shohet
Journal:  Blood       Date:  1984-02       Impact factor: 22.113

10.  Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes.

Authors:  S K Das; R C Nair
Journal:  Br J Haematol       Date:  1980-01       Impact factor: 6.998

View more
  11 in total

1.  Featured Article: Alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood.

Authors:  Eric Soupene; Mark S Borja; Mauricio Borda; Sandra K Larkin; Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2016-06-27

Review 2.  Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Authors:  Eboni I Lance; James F Casella; Allen D Everett; Emily Barron-Casella
Journal:  Proteomics Clin Appl       Date:  2014-11-06       Impact factor: 3.494

Review 3.  Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicine.

Authors:  Steven R Goodman; Betty S Pace; Kirk C Hansen; Angelo D'alessandro; Yang Xia; Ovidiu Daescu; Stephen J Glatt
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

4.  Featured Article: Depletion of HDL3 high density lipoprotein and altered functionality of HDL2 in blood from sickle cell patients.

Authors:  Eric Soupene; Sandra K Larkin; Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-24

Review 5.  A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic.

Authors:  Nirmani Yasara; Anuja Premawardhena; Sachith Mettananda
Journal:  Orphanet J Rare Dis       Date:  2021-03-01       Impact factor: 4.123

Review 6.  From the Cradle to the Grave: The Role of Macrophages in Erythropoiesis and Erythrophagocytosis.

Authors:  Thomas R L Klei; Sanne M Meinderts; Timo K van den Berg; Robin van Bruggen
Journal:  Front Immunol       Date:  2017-02-02       Impact factor: 7.561

Review 7.  The Shape Shifting Story of Reticulocyte Maturation.

Authors:  Elina Ovchynnikova; Francesca Aglialoro; Marieke von Lindern; Emile van den Akker
Journal:  Front Physiol       Date:  2018-07-11       Impact factor: 4.566

Review 8.  K+-Cl- cotransporter 1 (KCC1): a housekeeping membrane protein that plays key supplemental roles in hematopoietic and cancer cells.

Authors:  A P Garneau; S Slimani; L E Tremblay; M J Fiola; A A Marcoux; P Isenring
Journal:  J Hematol Oncol       Date:  2019-07-11       Impact factor: 17.388

Review 9.  Biologic complexity in sickle cell disease: implications for developing targeted therapeutics.

Authors:  Beatrice E Gee
Journal:  ScientificWorldJournal       Date:  2013-03-25

Review 10.  Red blood cell vesiculation in hereditary hemolytic anemia.

Authors:  Amr Alaarg; Raymond M Schiffelers; Wouter W van Solinge; Richard van Wijk
Journal:  Front Physiol       Date:  2013-12-13       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.